Burkholderia cepacia Talaromyces marneffei adult immunodeficiency neutralizing anti-interferon-γ autoantibodies

Journal

Infection and drug resistance
ISSN: 1178-6973
Titre abrégé: Infect Drug Resist
Pays: New Zealand
ID NLM: 101550216

Informations de publication

Date de publication:
2021
Historique:
received: 29 03 2021
accepted: 02 06 2021
entrez: 18 6 2021
pubmed: 19 6 2021
medline: 19 6 2021
Statut: epublish

Résumé

A high titer of neutralizing anti-interferon-γ autoantibodies can cause immunodeficiency associated with severe or disseminated infections caused by

Identifiants

pubmed: 34140785
doi: 10.2147/IDR.S312042
pii: 312042
pmc: PMC8203193
doi:

Types de publication

Case Reports

Langues

eng

Pagination

2173-2177

Informations de copyright

© 2021 Zeng et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

N Engl J Med. 2012 Aug 23;367(8):725-34
pubmed: 22913682
Blood. 2013 Feb 21;121(8):1357-66
pubmed: 23243276
Blood. 2012 Apr 26;119(17):3933-9
pubmed: 22403254
J Microbiol Immunol Infect. 2018 Apr;51(2):235-242
pubmed: 28847713
J Spine Surg. 2019 Sep;5(3):372-377
pubmed: 31663049
Open Forum Infect Dis. 2020 Jan 31;7(2):ofaa035
pubmed: 32099846
Clin Vaccine Immunol. 2010 Jul;17(7):1132-8
pubmed: 20445006
Nat Med. 2016 Sep;22(9):994-1001
pubmed: 27525523
J Clin Immunol. 2021 Jan;41(1):221-223
pubmed: 32996007
Medicine (Baltimore). 2016 Jun;95(25):e3927
pubmed: 27336882
Open Forum Infect Dis. 2019 Oct 11;6(10):ofz208
pubmed: 31660325

Auteurs

Wen Zeng (W)

Department of Respiratory and Critical Medicine, The Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong, 518000, People's Republic of China.
Department of Respiratory and Critical Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, People's Republic of China.

Ye Qiu (Y)

Department of Respiratory and Critical Medicine, The Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong, 518000, People's Republic of China.
Department of Respiratory and Critical Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, People's Republic of China.

Mengxin Tang (M)

Department of Respiratory and Critical Medicine, The Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong, 518000, People's Republic of China.
Department of Respiratory and Critical Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, People's Republic of China.

Hui Zhang (H)

Department of Respiratory and Critical Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, People's Republic of China.

Mianluan Pan (M)

Department of Respiratory and Critical Medicine, The Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong, 518000, People's Republic of China.

Shudan Tang (S)

Department of Respiratory and Critical Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, People's Republic of China.

Jianquan Zhang (J)

Department of Respiratory and Critical Medicine, The Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong, 518000, People's Republic of China.

Classifications MeSH